Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gilissen

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Medicine|September 20, 2021
Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort studyLennard P L Gilissen, Stefan G H Heinen, Lotte Rijpma-Jacobs, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 18, 2007
Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patientsN K H de Boer, P E Zondervan, L P L Gilissen, et al.
Therapeutic Drug Monitoring|May 29, 2004
Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapyLuc J J Derijks, Lennard P L Gilissen, Leopold G J B Engels, et al.
Surgical Endoscopy|November 7, 2020
Customized bariatric stents for sleeve gastrectomy leak: are they superior to conventional esophageal stents? A systematic review and proportion meta-analysisHytham K S Hamid, Sameh H Emile, Alan A Saber, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapyLennard P L Gilissen, Dennis R Wong, Leopold G J B Engels, et al.
Journal of Clinical Medicine|September 14, 2024
Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis-The OPTIMISE StudySilvio Danese, Gionata Fiorino, Eric Vicaut, et al.
Inflammatory Bowel Diseases|February 4, 2021
Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel DiseaseShaden Mahmmod, Johannes P D Schultheiss, Ad A van Bodegraven, et al.
Alimentary Pharmacology & Therapeutics|July 10, 2024
Multicentre study and systematic review: Allopurinol exposure during pregnancyFemke Crouwel, Melek Simsek, Marjon A de Boer, et al.
World Journal of Gastroenterology|October 14, 2005
On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patientsNanne-K-H de Boer, Luc-J-J Derijks, Lennard-P-L Gilissen, et al.
Gastroenterology|December 29, 2023
Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled TrialLia C M J Goltstein, Karina V Grooteman, Lucas H P Bernts, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Medicine|September 20, 2021
Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort studyLennard P L Gilissen, Stefan G H Heinen, Lotte Rijpma-Jacobs, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 18, 2007
Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patientsN K H de Boer, P E Zondervan, L P L Gilissen, et al.
Therapeutic Drug Monitoring|May 29, 2004
Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapyLuc J J Derijks, Lennard P L Gilissen, Leopold G J B Engels, et al.
Surgical Endoscopy|November 7, 2020
Customized bariatric stents for sleeve gastrectomy leak: are they superior to conventional esophageal stents? A systematic review and proportion meta-analysisHytham K S Hamid, Sameh H Emile, Alan A Saber, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapyLennard P L Gilissen, Dennis R Wong, Leopold G J B Engels, et al.
Journal of Clinical Medicine|September 14, 2024
Clinical Trial: A Pragmatic Randomised Controlled Study to Assess the Effectiveness of Two Patient Management Strategies in Mild to Moderate Ulcerative Colitis-The OPTIMISE StudySilvio Danese, Gionata Fiorino, Eric Vicaut, et al.
Inflammatory Bowel Diseases|February 4, 2021
Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel DiseaseShaden Mahmmod, Johannes P D Schultheiss, Ad A van Bodegraven, et al.
Alimentary Pharmacology & Therapeutics|July 10, 2024
Multicentre study and systematic review: Allopurinol exposure during pregnancyFemke Crouwel, Melek Simsek, Marjon A de Boer, et al.
World Journal of Gastroenterology|October 14, 2005
On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patientsNanne-K-H de Boer, Luc-J-J Derijks, Lennard-P-L Gilissen, et al.
Gastroenterology|December 29, 2023
Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled TrialLia C M J Goltstein, Karina V Grooteman, Lucas H P Bernts, et al.
Pageof 6